Effect of Fractional Carbon di-oxide Laser in primary cutaneous Macular Amyloidosis
Not Applicable
- Conditions
- Health Condition 1: L819- Disorder of pigmentation, unspecifiedHealth Condition 2: E858- Other amyloidosis
- Registration Number
- CTRI/2021/03/031982
- Lead Sponsor
- Dr Roshany V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with clinical diagnosis of Primary Cutaneous macular amyloidosis.
2. Patients with age 18 years and above.
Exclusion Criteria
1. Pregnant or breastfeeding women.
2. Personal history of hypertrophic scarring, keloids, melanoma or other skin cancer.
3. Patients on anti-coagulant therapy.
4. Those who had been previously treated with any laser within 3 months and any topical
hypopigmenting agents within 1 month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method